BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1929728)

  • 1. [N-acetylaspartic aciduria. Clinical, biological and physiopathological study].
    Gay C; Divry P; Macabeo V; Gilly R
    Arch Fr Pediatr; 1991; 48(6):409-13. PubMed ID: 1929728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Matalon R; Michals K; Sebesta D; Deanching M; Gashkoff P; Casanova J
    Am J Med Genet; 1988 Feb; 29(2):463-71. PubMed ID: 3354621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spongy degeneration of the neuraxis (Canavan-van Bogaert disease) and N-acetylaspartic aciduria.
    Echenne B; Divry P; Vianey-Liaud C
    Neuropediatrics; 1989 May; 20(2):79-81. PubMed ID: 2739878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylaspartic aciduria in Canavan disease: another proof in two infants.
    Yalaz K; Topçu M; Topaloğlu H; Gürçay O; Ozcan OE; Onol B; Renda Y
    Neuropediatrics; 1990 Aug; 21(3):140-2. PubMed ID: 2234319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.
    Divry P; Mathieu M
    Am J Med Genet; 1989 Apr; 32(4):550-1. PubMed ID: 2774002
    [No Abstract]   [Full Text] [Related]  

  • 6. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organic aciduria in Canavan disease].
    Elpeleg ON; Amir N; Glick B; Gross-Tzur V; Zelnik N; Tamiri Z
    Harefuah; 1989 Dec; 117(11):366-8. PubMed ID: 2620877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings.
    Zafeiriou DI; Kleijer WJ; Maroupoulos G; Anastasiou AL; Augoustidou-Savvopoulou P; Papadopoulou F; Kontopoulos EE; Fagan E; Payne S
    Brain Dev; 1999 Apr; 21(3):205-8. PubMed ID: 10372908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canavan disease: value of N-acetylaspartic aciduria?
    de Coo IF; Bakkeren JA; Gabreëls FJ
    Neuropediatrics; 1991 May; 22(2):III. PubMed ID: 1857492
    [No Abstract]   [Full Text] [Related]  

  • 10. Canavan disease and N-acetylaspartic aciduria.
    Elpeleg ON; Amir N; Barash V; Glick B; Gross-Tsur V; Shachar E; Shapira Y; Tzelnik N
    Neuropediatrics; 1989 Nov; 20(4):238. PubMed ID: 2608171
    [No Abstract]   [Full Text] [Related]  

  • 11. [Megalencephaly with dystonia revealing Canavan disease].
    Maaloul I; Fourati H; Wali M; Chabchoub I; Kamoun T; Mnif Z; Kaabachi N; Hachicha M
    Arch Pediatr; 2013 Jul; 20(7):783-6. PubMed ID: 23727372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of N-acetylaspartic acid induces oxidative stress to contribute in disease pathophysiology.
    Surendran S; Bhatnagar M
    Int J Neurosci; 2011 Jun; 121(6):305-9. PubMed ID: 21348802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism.
    Tavazzi B; Lazzarino G; Leone P; Amorini AM; Bellia F; Janson CG; Di Pietro V; Ceccarelli L; Donzelli S; Francis JS; Giardina B
    Clin Biochem; 2005 Nov; 38(11):997-1008. PubMed ID: 16139832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical MRI findings in Canavan disease: a patient with a mild course.
    Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
    Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylaspartic aciduria in young age.
    Elpeleg ON
    Neuropediatrics; 1992 Apr; 23(2):112. PubMed ID: 1603285
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical diagnosis of Canavan disease.
    Bartalini G; Margollicci M; Balestri P; Farnetani MA; Cioni M; Fois A
    Childs Nerv Syst; 1992 Dec; 8(8):468-70. PubMed ID: 1288858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylaspartic aciduria in a child with a progressive cerebral atrophy.
    Kvittingen EA; Guldal G; Børsting S; Skalpe IO; Stokke O; Jellum E
    Clin Chim Acta; 1986 Aug; 158(3):217-27. PubMed ID: 3769199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of N-acetylaspartic acid in urine by LC-MS/MS for the diagnosis of Canavan disease.
    Al-Dirbashi OY; Rashed MS; Al-Qahtani K; Al-Mokhadab MA; Kurdi W; Al-Sayed MA
    J Inherit Metab Dis; 2007 Aug; 30(4):612. PubMed ID: 17632691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan disease: a review of recent developments.
    Gordon N
    Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organic acid disorders: cerebral organic acidemia].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):162-8. PubMed ID: 12483853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.